Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests

Tempest Therapeutics, Inc. (TPST) reported Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-11.

Discontinued › Shareholders' Equity › Noncontrolling Interest Items

us-gaap:MinorityInterestDecreaseFromRedemptions · last filed 2020-03-11

  • Tempest Therapeutics, Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
  • Tempest Therapeutics, Inc. noncontrolling interest, decrease from redemptions or purchase of interests for fiscal 2018 was $9.79M.
Period endNoncontrolling Interest, Decrease from Redemptions or Purchase of Interests 12 month
2019-12-31$0.00
10-K · filed 2020-03-11
2018-12-31$9.79M
10-K · filed 2020-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B